Option chain shows key data for Destiny Tech100's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Destiny Tech100.

Destiny Tech100 (NYSE:DXYZ) Stock, Option Chain

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

The Boeing Co. (NYSE- BA)

News

SPACE

Tech

DXYZ

Boeing has reportedly appointed its international space station (ISS) program manager John Mulholland as the leader of the Starliner program.

After Stranding 2 Astronauts At ISS For Months, Boeing Replaces The Head Of Its Starliner Program

OpenAI CEO Sam Altman

Media

INTC

MSFT

OpenAI CEO Sam Altman Predicts AGI Will Arrive During The Trump Presidency, Says CHIPS Act Not Effective Enough

Starlink Photo by Wirestock Creators on Shutterstock

General

TMUS

ARKVX

Kyivstar has signed an agreement with Starlink to offer satellite connectivity.

Elon Musk&#39;s Starlink To Bring Space-Based Mobile Connectivity To Ukraine

Destiny Tech100 Inc

Avista (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVA#NYSE">AVA</a>) reported quarterly earnings of $0.84 per share which missed the analyst consensus estimate of $0.89 by 5.62 percent. This is a 22.22 percent decrease over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $517.00 million which beat the analyst consensus estimate of $480.62 million by 7.57 percent. This is a 2.49 percent increase over sales of $504.44 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Avista Q4 2024 GAAP EPS $0.84 Misses $0.89 Estimate, Sales $517.00M Beat $480.62M Estimate

Sprott (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SII#NYSE">SII</a>) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.48 by 4.17 percent. This is a 21.05 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $36.80 million which missed the analyst consensus estimate of $38.30 million by 3.89 percent. This is a 1.84 percent increase over sales of $36.14 million the same period last year.

Sprott Q4 EPS $0.46 Misses $0.48 Estimate, Sales $36.80M Miss $38.30M Estimate

Biotech

CGTX

Cognition Therapeutics Says Masked Analysis Showed Participants Receiving Oral Zervimesine For At Least Least 6 Months Experienced Slower Lesion Growth Than Participants Receiving Placebo

Editor&#8217;s Note: This story has been updated with additional information.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) researcher Troy Teslike on Wednesday said that the EV company will likely not deliver 500,000 vehicles in a quarter in 2025 either, mostly owing to &#8220;brand sentiment issues.&#8221;
What Happened: The highest deliveries by Tesla in a quarter to date was in the fourth quarter of 2024 when the company delivered 495,570 vehicles. The company was aiming for over 500,00 deliveries but fell short because of demand issues. 
&#8220;Sadly reaching 500,000 in a single quarter doesn't seem possible this year either, mostly because of brand sentiment issues,&#8221; Teslike said in a post on social media platform X. 
&#8220;This year's best quarter will likely be below 470,000 units but the situation seems to be getting worse, and soon even 450,000 might be hard to achieve,&#8221; Teslike said. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla delivered 495,570 cars in Q4 2024. They came very close to 500,000 but didn't quite make it because of demand issues. Sadly, reaching 500,000 in a single quarter doesn't seem possible this year either, mostly because of brand sentiment issues. This year's best quarter will… <a href="https://t.co/HjT0kyzwe2">pic.twitter.com/HjT0kyzwe2</a>
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1894654134730530882?ref_src=twsrc%5Etfw">February 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The sentiment around Tesla is deteriorating owing to Elon Musk&#8217;s association with President Donald Trump and his support for far-right leaders and parties such as Alternative for Germany. The Department of Government Efficiency, led by Musk and aimed at slashing federal government spending, is also firing or forcing out government workers across departments, giving rise to protests.
Why It Matters: Tesla reported a fall in vehicle deliveries for the first time in over a decade in 2024. Tesla reported global&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a>&nbsp;vehicles, down from full-year deliveries of 1.81 million in 2023.
In the democratic state of California, Tesla had only 203,221 vehicle registrations in 2024, nearly 12% lower than the year before, according to data from the California New Car Dealers Association (CNCDA).
Deliveries are not faring well since the start of this year either.
According to data from the China Passenger Car Association, <a href="https://www.benzinga.com/tech/25/02/43556649/tesla-drops-1-5-premarket-after-sales-of-china-made-evs-in-january-drop-11-5-yoy">Tesla&#8217;s China-made EV sales fell 11.5% to 63,238 units in January</a>. Of these 29,535 were exported to outside China.
In the European Union, Tesla&#8217;s new car registration<a href="https://www.benzinga.com/25/02/43934934/new-tesla-registrations-dip-by-50-in-eu-in-january-despite-rising-overall-bev-market-share"> fell by over 50%</a> in January despite a rise in overall battery electric vehicle registrations, according to data from the European Automobile Manufacturers Association (ACEA).
Tesla CEO Elon Musk said in October that he expects a 20-30% increase in deliveries in 2025. However, the CEO didn't reiterate the target during the company's fourth-quarter earnings in January. Instead, Tesla only said that it expects the vehicle business to "return to growth" in 2025, possibly implying that deliveries would be higher than in 2024.
Tesla did not immediately respond to Benzinga&#8217;s request for comment.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43966461/lucid-to-up-production-increase-advertising-and-sell-in-saudi-arabia-to-up-high-end-gravity-suv-sales-this-year">Lucid Gravity Customers Opting For High-End Configurations, All The Way Up To $120,000: CEO Says SUV &#8216;Attracting New People To The Brand&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

TSLA

Tesla Unlikely To Deliver 500,000 EVs In A Quarter In 2025, Says Researcher: 'Doesn't Seem Possible This Year Either' (UPDATED)

Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.47 by 10.64 percent. This is a 8.33 percent increase over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $212.14 million which beat the analyst consensus estimate of $210.00 million by 1.02 percent. This is a 1.94 percent decrease over sales of $216.33 million the same period last year.

PLAB

Photronics Q1 2025 Adj EPS $0.52 Beats $0.47 Estimate, Sales $212.14M Beat $210.00M Estimate

Guidance

AVNS

Avanos Medical Sees 2025 Net Sales To Be Between $665M-$685M Vs. $713.13M Estimate, And Adjusted Diluted Earnings Per Share Are Expected To Be Between $1.05-$1.25 Vs. $1.67 Estimate

SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.06) by 166.67 percent. This is a 300 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $75.49 million which beat the analyst consensus estimate of $74.18 million by 1.76 percent. This is a 4.63 percent decrease over sales of $79.15 million the same period last year.

SKYT

SkyWater Technology Q4 2024 Adj EPS $0.04 Beats $(0.06) Estimate, Sales $75.49M Beat $74.18M Estimate

For the full year 2025, the Company expects net sales to be in the range of $158 million to $163 million, and an adjusted EBITDA loss in the range of $8 million to $11 million. Adjusted EBITDA guidance reflects a planned increase in marketing and promotional spend as the Company reinvests cost savings into future growth.
For the first quarter of 2025, the Company expects net sales to be in the range of $36 million to $38 million, and an adjusted EBITDA loss of between $5.6 million and $6.0 million. The net sales guidance reflects the impacts of the aforementioned lost distribution in our club channel and one customer in our mass channel. Adjusted EBITDA reflects planned reinvestment in marketing spend, particularly in the first and third quarters of 2025.

ZVIA

Zevia Expects Q1 Revenue Of $36M-$38M Vs $42.36M Est, FY25 Revenue Of $158M-$163M Vs $167.24M Est

Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) reported quarterly losses of $(0.72) per share which met the analyst consensus estimate. This is a 2.86 percent decrease over losses of $(0.70) per share from the same period last year. The company reported quarterly sales of $41.83 million which beat the analyst consensus estimate of $38.48 million by 8.69 percent. This is a 72.61 percent increase over sales of $24.23 million the same period last year.

RYTM

Rhythm Pharmaceuticals Q4 EPS $(0.72), Inline, Sales $41.83M Beat $38.48M Estimate

Barclays analyst Ryan Macwilliams maintains Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) with a Equal-Weight and lowers the price target from $85 to $80.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Zoom Communications, Lowers Price Target to $80

Needham analyst Mayank Tandon reiterates PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) from Hold to Hold.

Reiteration

PYPL

Needham Reiterates Hold on PayPal Holdingsto Hold

Barclays analyst Jiong Shao maintains Sea (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) with a Overweight and raises the price target from $131 to $148.

Barclays Maintains Overweight on Sea, Raises Price Target to $148

Dycom Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DY#NYSE">DY</a>) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $0.90 by 30 percent. This is a 48.1 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $1.08 billion which beat the analyst consensus estimate of $1.03 billion by 5.60 percent. This is a 13.81 percent increase over sales of $952.46 million the same period last year.

Dycom Industries Q4 2025 Adj EPS $1.17 Beats $0.90 Estimate, Sales $1.08B Beat $1.03B Estimate

This approval triggers a $5 million milestone payment to Ardelyx under the terms of the license agreement between Ardelyx and its collaboration partner in China, Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Fosun Pharma). Under the terms of its agreement,&nbsp;Ardelyx is eligible to receive additional developmental and commercialization milestones of up to&nbsp;$100 million&nbsp;and tiered royalty payments on net sales ranging from the mid-teens to 20 percent.

ARDX

Ardelyx's Tenapanor Approved In China For Hyperphosphatemia, Triggering $5M Milestone Payment

2025 Financial Outlook
The Company is sharing the following financial outlook for the full year 2025:
<ul>
<li>Total revenues in the range of $1,461 million to $1,490 million, or $1,481 million to $1,510 million in constant currency;</li>
<li>Subscriptions revenues growth rate of 10.5% to 12.5% in constant currency;</li>
<li>Perpetual licenses revenues growth rate approximately flat in constant currency;</li>
<li>Services revenues growth rate approximately flat in constant currency;</li>
<li>Constant currency ARR growth rate (business performance, including programmatic acquisitions) of 10.5% to 12.5%;</li>
<li>Adjusted OI w/SBC margin of approximately 28.5% (representing annual improvement of 100 bps);</li>
<li>Effective tax rate of approximately 21%;</li>
<li>Free cash flows in the range of $415 million to $455 million; and</li>
<li>Capital expenditures of approximately $20 million.</li>
</ul>

Bentley Systems Expects FY25 Revenue Of $1.461B-$1.490B Vs $1.496B Est

EYEN

Eyenovia Regains Compliance With Nasdaq Continued Listing Requirements

AerCap Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>) reported quarterly earnings of $3.31 per share which beat the analyst consensus estimate of $2.57 by 28.79 percent. This is a 6.43 percent increase over earnings of $3.11 per share from the same period last year. The company reported quarterly sales of $2.07 billion which beat the analyst consensus estimate of $1.96 billion by 5.61 percent. This is a 9.11 percent increase over sales of $1.90 billion the same period last year.

AerCap Holdings Q4 2024 Adj EPS $3.31 Beats $2.57 Estimate, Sales $2.07B Beat $1.96B Estimate

Vita Coco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCO#NASDAQ">COCO</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.08 by 25 percent. This is a 45.45 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $127.29 million which beat the analyst consensus estimate of $120.91 million by 5.28 percent. This is a 19.92 percent increase over sales of $106.14 million the same period last year.

COCO

Vita Coco Q4 EPS $0.06 Misses $0.08 Estimate, Sales $127.29M Beat $120.91M Estimate

Stephens &amp; Co. analyst Jim Salera maintains Portillos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>) with a Equal-Weight and raises the price target from $13 to $14.

PTLO

Stephens & Co. Maintains Equal-Weight on Portillos, Raises Price Target to $14

PayPal Holdings Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) has made several announcements and shared its growth strategy for the upcoming years, on its investor day on Tuesday attracting mixed response from analysts.
What Happened: Among other <a href="https://www.benzinga.com/25/02/43942860/paypal-eyes-double-digit-eps-growth-by-2027-teams-up-with-verifone-jp-morgan-more">important announcements,</a> the fintech giant introduced its latest merchant product, PayPal Open, a unified platform that provides businesses with a comprehensive range of checkout solutions, including PayPal, Venmo, Fastlane, and Pay Later options.
The company also renamed Braintree to PayPal Enterprise Payments as part of its rebranding. Additionally, PayPal revealed an enhanced sales partnership with point-of-sale terminal provider Verifone.
PayPal forecasted that its non-GAAP EPS will grow by a percentage in the low teens by 2027, with a long-term growth target of 20%. Additionally, the company anticipates transaction margin dollars to rise by high single digits by 2027 and exceed 10% growth in the long run.
In a regulatory filing, PayPal announced executive vice president and CFO, Jamie Miller, has been appointed to the expanded role of chief financial and operating officer. 
SEE ALSO: <a href="https://www.benzinga.com/news/25/02/43962364/president-trump-says-inflation-is-back-claims-its-not-his-fault-but-bidens-i-had-nothing-to-do-with-it">President Trump Says, &#8216;Inflation Is Back,&#8217; Claims It&#8217;s Not His Fault But Biden&#8217;s—&#8217;I Had Nothing To Do With It&#8217;</a>
Why It Matters: PayPal posted strong fourth-quarter results with consensus beating revenue and earnings. Its investor day announcements were awaited by investors who are watching the strategic moves of the company amid competition from Apple Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Apple Pay.
However, the announcements have received mixed reactions from analysts. Barclays analyst Ramsey El-Assal wrote in an investor note, "PayPal laid out a very compelling vision of the future, with the company set to pivot away from ‘payments' and into ‘commerce,'" reported MarketWatch. TD Cowen analyst Bryan Bergin rated the stock as &#8216;Hold&#8217; with a price target of $83. Bergin also called the fintech giant&#8217;s 2027 targets &#8216;ambitious&#8217;, as per Barrons.
Meanwhile, William Blair analyst Andrew Jeffrey suggested a cautious approach for investors citing competition from Apple Pay. He also wrote, "We have particularly low conviction that&nbsp;PayPal&nbsp;can drive a higher long-term transaction yield, creating a headwind to transaction dollar growth."
The PayPal stock soared nearly 25% over the past 12 months but declined 14.5% year-to-date, as per data from <a href="https://pro.benzinga.com/dashboard">BenzingaPro</a>.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/news/earnings/25/02/43958373/workday-shares-climb-after-q4-report-heres-why">Workday Shares Climb After Q4 Report: Here&#8217;s Why</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments

Destiny Tech100

Destiny Tech100 (DXYZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga